Omicron News and Research

RSS
The effectiveness of nirmatrelvir-ritonavir and molnupiravir for the treatment of COVID-19 among US veterans

The effectiveness of nirmatrelvir-ritonavir and molnupiravir for the treatment of COVID-19 among US veterans

Detection of unreported infections based on SARS-CoV-2 antibody seroprevalence

Detection of unreported infections based on SARS-CoV-2 antibody seroprevalence

Immunogenicity of SARS-CoV-2 antibody response in immune naïve children and adults

Immunogenicity of SARS-CoV-2 antibody response in immune naïve children and adults

XBB Omicron variant evades vaccine-induced immunity

XBB Omicron variant evades vaccine-induced immunity

The benefit-risk of the mRNA-1273 COVID-19 vaccine

The benefit-risk of the mRNA-1273 COVID-19 vaccine

Study shows emerging Omicron sublineages efficiently evade neutralization independent of immunization history

Study shows emerging Omicron sublineages efficiently evade neutralization independent of immunization history

What is the incidence of viral rebound after treatment with nirmatrelvir-ritonavir and molnupiravir?

What is the incidence of viral rebound after treatment with nirmatrelvir-ritonavir and molnupiravir?

Intranasal recombinant MVA-based vaccines effective against SARS-CoV-2 variants in mice

Intranasal recombinant MVA-based vaccines effective against SARS-CoV-2 variants in mice

How convergent evolution is creating new COVID-19 waves

How convergent evolution is creating new COVID-19 waves

Characterization of SARS-CoV-2 Omicron BQ.1.1

Characterization of SARS-CoV-2 Omicron BQ.1.1

Research explores cell receptors for bat viruses to understand emergence of zoonotic diseases

Research explores cell receptors for bat viruses to understand emergence of zoonotic diseases

Exploring a variant-adapted SARS-CoV-2 recombinant protein vaccine

Exploring a variant-adapted SARS-CoV-2 recombinant protein vaccine

Booster COVID-19 mRNA vaccinations marginally increase the durability of neutralizing antibody responses

Booster COVID-19 mRNA vaccinations marginally increase the durability of neutralizing antibody responses

Scientists develop new receptor “decoy” drug that potently neutralizes SARS-CoV-2 variants

Scientists develop new receptor “decoy” drug that potently neutralizes SARS-CoV-2 variants

What was the SARS-CoV-2 seroprevalence among US adults during 2021 and 2022?

What was the SARS-CoV-2 seroprevalence among US adults during 2021 and 2022?

Researchers explore the correlation between the dynamic shedding pattern of SARS-CoV-2 and viral load

Researchers explore the correlation between the dynamic shedding pattern of SARS-CoV-2 and viral load

Study predicts persistent cross-species SARS-CoV-2 variant infectivity

Study predicts persistent cross-species SARS-CoV-2 variant infectivity

Long Covid symptoms experienced by children and young people change over time, study finds

Long Covid symptoms experienced by children and young people change over time, study finds

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.